CI Platform
Sign in
BLS Pharmaceuticals LimitedBLSDUS FRA HAM BLN ASX
Current ReportFundamental Reports

Australasia / AUSTRALIA

Report Sections1

Available for this company

Reporting UnitMillions

DUS FRA HAM BLN ASX

To continue to view the full report

Buy this company's report, or subscribe to a plan.

Buy ReportSubscribe PlansAlready a member? Sign in

Company Overview

BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.

BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.

Includes quarterly earnings and dividends.

Company Details

Major IndustryCommercial Services & Supplies
Sub IndustryCommercial Physical Research
CountryAUSTRALIA
Employeesn/a
Reporting UnitMillions
Primary ExchangeDUS FRA HAM BLN ASX
Instrument TypeEquity
Websitehttp://www.bioxyne.com
Wright IDC036BYL9H

Key Metrics

Current price$0.99
Market cap$232.5 M
P/E ratio14.70
52-week perf.+146.3%
Common shares236.1 M
Closely held161.2 M
Share typeOrdinary
Quality ratingLAB20
Dividend yield0.00%

Recent stock performance

1 Week-3.9%
4 Week-3.4%
13 Week+21.6%

Officers

ChairmanAnthony Ho
Chief Executive & Managing DirectorNam Hoat Chua
Chief Financial Officer, Chief Operating Officer & SecretaryGuy Adrian Robertson

Address

SE 506 L 5 50 Clarence Street

SYDNEY, New South Wales

AUSTRALIA

2000

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.